Indeed, the early tumorigenesis studies using the 172H/+ mice showed that these had an altered cancer spectrum and increased metastases that was distinct from the p53 null mice (Lang et al, 2004; Olive et al, 2004). The gene discussed is TP53; the disease is cancer.